Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11,930 GBX | -0.81% | -3.48% | +12.55% |
29/05 | Fusion Pharmaceuticals Shareholders Approve AstraZeneca Deal | MT |
29/05 | AstraZeneca drug lowers cholesterol in phase 1 trial | AN |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.55% | 24TCr | |
+39.22% | 73TCr | |
+30.57% | 59TCr | |
-7.85% | 35TCr | |
+15.48% | 32TCr | |
-0.12% | 27TCr | |
+6.65% | 20TCr | |
-6.09% | 20TCr | |
-3.37% | 16TCr | |
-2.28% | 12TCr |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca, Merck Sue Over Cancer Drug Patent Infringement